Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $24.0961 per ML under NDC 62756009040. Its NADAC has been published 259 times since Dec 4, 2019.
FDA first approved this application on May 1, 2019.
Strength
150 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756009040
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
10/23/2024
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210760FDA Approved
5/1/2019
On Market Since
5/4/2019
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 259 times since Dec 4, 2019, and over the history we have for it it has declined 40.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.0961 per ML |
|---|---|
| All-time high | $40.7090 (Jan 15, 2020) |
| All-time low | $16.1873 (Jul 17, 2024) |
| Median price | $29.2165 |
| Average price | $30.0544 |
| Largest weekly change | +50.7% (Aug 21, 2024) |
| Weeks tracked | 259 |
| Tracking since | Dec 4, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-12.7%
5Y
-20.0%
All
-40.2%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MEDROXYPROGESTERONE ACETATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Sun Pharmaceutical Industries Inc., is $24.0961 per ML (NDC 62756009040), effective Nov 13, 2024.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 40.2%. It has been tracked across 259 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Dec 4, 2019, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $16.1873 (Jul 17, 2024) to a high of $40.7090 (Jan 15, 2020), with a median of $29.2165 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.8535 per ML — about 22% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 62756009040) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.